UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Qurient sets up joint firm with Nobel chemistry prize winner
Qurient has established a joint venture with Professors Robert Huber, a res...
by Lee Han-soo
|
2019-10-04 17:45
라인
Lilly's Verzenio extends life for women with advanced breast cancer
Lilly said a combination therapy of Verzenio and fulvestrant significantly ...
by Lee Han-soo
|
2019-10-04 16:15
라인
‘New law to support advanced biopharmaceuticals, ensure safety’
The Ministry of Food and Drug Safety is preparing to implement the “Act on ...
by Lee Hye-seon
|
2019-10-04 15:18
라인
Regulator under fire for neglecting reported side effects of Invossa
The Ministry of Food and Drug Safety has come under criticism for doing lit...
by Lee Han-soo
|
2019-10-04 14:59
라인
Severance confirms efficacy, safety of Yuhan's lung cancer drug Lazertinib
Severance Hospital said it has published research results on the efficacy a...
by Lee Han-soo
|
2019-10-04 14:39
라인
Samsung execs pass buck to biotech subsidiaries for destroying evidence
Samsung executives said Samsung BioLogics and Samsung Bioepis workers were ...
by Jeong Sae-im
|
2019-10-04 11:42
라인
Foreign patients visiting Korea rise by 17.8% in 2018
The number of foreigners getting medical treatment in Korea increased last ...
by Lee Han-soo
|
2019-10-02 17:50
라인
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
The government said it would grant insurance benefit to Eisai’s Lenvima (in...
by Lee Han-soo
|
2019-10-02 16:10
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi
|
2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX
Daewoong Pharmaceutical said that Evolus, its U.S. and EU partner, has rece...
by Lee Han-soo
|
2019-10-02 14:51
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon
|
2019-10-02 14:51
라인
Anorexia craze among Korean girls raises concerns
The fear of weight gain and the desire to be slim has become a real health ...
by Lee Han-soo
|
2019-10-02 11:34
라인
Regulator raids cell therapy makers too often to little avail
In the wake of the recall of cell gene therapy Invossa-K, the Ministry of F...
by Jeong Sae-im
|
2019-10-02 11:23
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo
|
2019-10-01 16:43
라인
Cost of smartphone-related illness tops ₩400 billion in 2018
Medical expenses to treat smartphone-related diseases such as dry eye syndr...
by Lee Han-soo
|
2019-10-01 15:47
라인
Will parliamentary audit uncover why Invossa was mislabeled?
The National Assembly’s Health and Welfare Committee is expected to focus o...
by Jeong Sae-im
|
2019-10-01 15:45
라인
Researchers say global anti-thrombotic drug guideline too much for Koreans
Amid the controversy over the bleeding complications of anti-thrombotic dru...
by Lee Han-soo
|
2019-10-01 14:08
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun
|
2019-10-01 13:49
라인
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
Crystal Genomics said it has presented the results of the preclinical study...
by Lee Han-soo
|
2019-10-01 11:21
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi
|
2019-10-01 11:09
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top